Proteolysis-targeting chimeras (PROTACs) and molecular glue degraders (MGDs) are essentially the most maturely produced TPD methods. Within this evaluation, we concentrate on each preclinical experiments and scientific trials to deliver an extensive summary of the safety and scientific efficiency of PROTACs and MGDs in hematologic malignancies over the past two https://herodotusn776kdv8.wikiinside.com/user